阿尔茨海默氏病在活体人体微质细胞中的转录景观
Panos Roussos1, Roman Kosoy1, John Fullard1
1Icahn School of Medicine at Mount Sinai.
Research square
|February 12, 2024
概括
微质细胞,大脑的免疫细胞,在阿尔茨海默病 (AD) 中显示出显著的转录性变化. 这项研究揭示了这些变化如何影响疾病严重程度,并为AD提供了潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 微质细胞是关键的大脑免疫细胞,参与阿尔茨海默氏症 (AD) 病原发生.
- 在AD中控制微质功能的特定分子和细胞机制在很大程度上是未知的.
研究的目的:
- 为了研究微质细胞的转录景观,在人类大脑衰老和阿尔茨海默氏症 (AD) 现型的频谱中.
- 为了确定与AD严重程度和神经病理学相关的微质中的分子变化.
主要方法:
- 从189个人类死后大脑样本的转录资料分析,包括健康的衰老和各种AD阶段.
- 检查基因表达,异型的使用,以及微质内基因-基因协调.
主要成果:
- 确定了与多个AD表型和疾病严重程度相关的微质中的广泛的转录性变化.
- 在AD微质中发现异质异构形式的使用和改变基因-基因协调.
- 揭示了不同的微质基因表达模式,对应于不同的AD亚型.
结论:
- 微质在阿尔茨海默病 (AD) 生物学中发挥着关键作用,观察到显著的转录失调.
- 这项研究为AD的微质异质性提供了新的见解.
- 基于微质基因表达变化,确定了针对阿尔茨海默病的干预潜在的治疗点.
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


